Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Sulphonylurea + biguanide + thiazolidinedione triple OAD
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes uncontrolled on dual OAD
- Patients with significant insulin resistance
- Glycaemic intensification prior to insulin
Mechanism of Action
Glibenclamide closes ATP-sensitive K+ channels on pancreatic beta cells, depolarising them and triggering insulin secretion. Metformin activates AMPK and suppresses hepatic glucose output while improving peripheral insulin sensitivity. Pioglitazone activates PPAR-gamma, increasing insulin-sensitive gene expression in adipose and skeletal muscle, reducing free-fatty-acid release.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast
- Titrate based on glycaemic response
- Monitor liver function and fluid retention
- Use under physician supervision
Side Effects
- Hypoglycaemia (sulphonylurea)
- GI upset (metformin)
- Weight gain and fluid retention (pioglitazone)
- Bladder cancer risk with long-term pioglitazone (debated)
Contraindications
- Type-1 diabetes
- Severe renal or hepatic impairment
- Heart failure NYHA Class III–IV
- Active bladder cancer
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet?
MRPs range from ₹790 to ₹790 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Glibenclamide 5 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet?